Overview

Statins and ARBs on Rheumatoid Activity

Status:
Recruiting

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Phase:

Phase 3

Details

Lead Sponsor:

Sherief Abd-Elsalam

Treatments:

Angiotensin Receptor Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors